Matched on what Harbor offers: medications, brand-name access, the video visit, an oral option, price and where it serves. Each one links to our full review.
Semaglutide from $119/mo
Pomegranate lists compounded semaglutide from $119 and tirzepatide from $159 a month, including care, medication and shipping without membership.
Why it's here: the same medications, compounded medication and no video visit.
- Pomegranate Health lists semaglutide at $119 a month; we couldn't find a recurring semaglutide price for Harbor.
- Neither Pomegranate Health nor Harbor requires a live video visit to get started.
Semaglutide from $197/mo · Tirzepatide from $297/mo
Starting prices of $197/mo semaglutide and $297/mo tirzepatide, compounded in the USA with no hidden fees stated directly — pricing had to be pulled from the site's own compiled app data since it never showed up on a plain page load.
Why it's here: the same medications, compounded medication and no video visit.
- RNK Health lists semaglutide at $197 a month; we couldn't find a recurring semaglutide price for Harbor.
- RNK Health lists tirzepatide at $297 a month; we couldn't find a recurring tirzepatide price for Harbor.
- Neither RNK Health nor Harbor requires a live video visit to get started.
Semaglutide from $249.97/mo · Tirzepatide from $349.97/mo
The household Q&A brand's weight-loss arm: semaglutide-plus-B12 and tirzepatide-plus-B12 on a four-tier commitment ladder, with a real ongoing price of $249.97/$349.97 after a cheaper first month — and its own ad-tracking code anchors to the 12-month-prepay rate instead.
Why it's here: the same medications, compounded medication and no video visit.
- JustAnswer Weight Loss lists semaglutide at $249.97 a month; we couldn't find a recurring semaglutide price for Harbor.
- JustAnswer Weight Loss lists tirzepatide at $349.97 a month; we couldn't find a recurring tirzepatide price for Harbor.
- Neither JustAnswer Weight Loss nor Harbor requires a live video visit to get started.
Semaglutide from $99/mo · Tirzepatide from $99/mo
One flat $99 a month for either molecule, medication and shipping included, once you get past a meta tag that's still quoting a stale $139 — the real number lives in its own rendered FAQ, which is the page a customer actually reads before paying.
Why it's here: the same medications, compounded medication and no video visit.
- Teleios Health lists semaglutide at $99 a month; we couldn't find a recurring semaglutide price for Harbor.
- Teleios Health lists tirzepatide at $99 a month; we couldn't find a recurring tirzepatide price for Harbor.
- Neither Teleios Health nor Harbor requires a live video visit to get started.
Semaglutide from $249/4 wks · Tirzepatide from $329/4 wks
Enhance publishes each plan price before intake. Semaglutide starts at $249 and tirzepatide at $329 per four weeks on the shortest plan; the $212/$280 rates require a forty-eight-week billing term.
Why it's here: the same medications, compounded medication and no video visit.
- Enhance MD lists semaglutide at $249 per 4 weeks; we couldn't find a recurring semaglutide price for Harbor.
- Enhance MD lists tirzepatide at $329 per 4 weeks; we couldn't find a recurring tirzepatide price for Harbor.
- Neither Enhance MD nor Harbor requires a live video visit to get started.
- Enhance MD lists a narrower service area; Harbor doesn't publish a full state list.
Semaglutide from $299/mo · Tirzepatide from $399/mo
It just tells you the price and then charges it — $299 or $399, injection or tablet, no first-month bait — and it puts its doctors' names on a public page.
Why it's here: the same medications, compounded medication and no video visit.
- Willow lists semaglutide at $299 a month; we couldn't find a recurring semaglutide price for Harbor.
- Willow lists tirzepatide at $399 a month; we couldn't find a recurring tirzepatide price for Harbor.
- Neither Willow nor Harbor requires a live video visit to get started.
- Willow lists an oral option (a pill or under-the-tongue form); Harbor doesn't.
- Willow lists a narrower service area; Harbor doesn't publish a full state list.